KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Change in Accured Expenses (2018 - 2025)

Historic Change in Accured Expenses for Steris (STE) over the last 8 years, with Q4 2025 value amounting to $25.6 million.

  • Steris' Change in Accured Expenses fell 1688.31% to $25.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $16.9 million, marking a year-over-year increase of 2359.72%. This contributed to the annual value of $38.9 million for FY2025, which is 254.29% down from last year.
  • Latest data reveals that Steris reported Change in Accured Expenses of $25.6 million as of Q4 2025, which was down 1688.31% from -$42.9 million recorded in Q3 2025.
  • Steris' 5-year Change in Accured Expenses high stood at $47.2 million for Q4 2023, and its period low was -$85.9 million during Q3 2022.
  • For the 5-year period, Steris' Change in Accured Expenses averaged around $1.4 million, with its median value being $10.6 million (2021).
  • Per our database at Business Quant, Steris' Change in Accured Expenses plummeted by 134400.69% in 2022 and then surged by 341001.56% in 2023.
  • Steris' Change in Accured Expenses (Quarter) stood at $17.3 million in 2021, then surged by 165.7% to $46.0 million in 2022, then rose by 2.63% to $47.2 million in 2023, then tumbled by 34.74% to $30.8 million in 2024, then decreased by 16.88% to $25.6 million in 2025.
  • Its last three reported values are $25.6 million in Q4 2025, -$42.9 million for Q3 2025, and -$9.2 million during Q2 2025.